Denali Therapeutics (DNLI) Tax Provisions (2019 - 2023)
Historic Tax Provisions for Denali Therapeutics (DNLI) over the last 5 years, with Q4 2023 value amounting to $30000.0.
- Denali Therapeutics' Tax Provisions rose 60000.0% to $30000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $24000.0, marking a year-over-year increase of 10433.21%. This contributed to the annual value of $68000.0 for FY2024, which is 12666.67% up from last year.
- Latest data reveals that Denali Therapeutics reported Tax Provisions of $30000.0 as of Q4 2023, which was up 60000.0% from -$6000.0 recorded in Q4 2022.
- Denali Therapeutics' Tax Provisions' 5-year high stood at $823000.0 during Q4 2020, with a 5-year trough of -$575000.0 in Q4 2021.
- Over the past 5 years, Denali Therapeutics' median Tax Provisions value was $27000.0 (recorded in 2022), while the average stood at -$4727.3.
- Per our database at Business Quant, Denali Therapeutics' Tax Provisions soared by 99733.33% in 2020 and then tumbled by 16986.63% in 2021.
- Denali Therapeutics' Tax Provisions (Quarter) stood at $75000.0 in 2019, then soared by 997.33% to $823000.0 in 2020, then plummeted by 169.87% to -$575000.0 in 2021, then skyrocketed by 98.96% to -$6000.0 in 2022, then skyrocketed by 600.0% to $30000.0 in 2023.
- Its Tax Provisions was $30000.0 in Q4 2023, compared to -$6000.0 in Q4 2022 and $27000.0 in Q2 2022.